Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Palisade Bio, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- +1 vs. Q3 2024
- Shares held
- 235.0K
- +137.1K (+140.1%) vs. Q3 2024
- Total value
- $387.7K
- +$40.3K (+11.6%) vs. Q3 2024
- New holders
- 2
- 4 more added
- Sold out
- 1
- 1 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PALI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $362.4M |
| Q1 2026 | 96 | $261.7M |
| Q4 2025 | 86 | $319.4M |
| Q3 2025 | 12 | $102.8K |
| Q2 2025 | 11 | $57.5K |
| Q1 2025 | 13 | $200.9K |
| Q4 2024 | 10 | $387.7K |
| Q3 2024 | 9 | $347.4K |
| Q2 2024 | 8 | $297.7K |
| Q1 2024 | 16 | $384.6K |
| Q4 2023 | 16 | $158.3K |
| Q3 2023 | 13 | $86.6K |
| Q2 2023 | 11 | $228.7K |
| Q1 2023 | 9 | $29.8K |
| Q4 2022 | 12 | $648.0K |
| Q3 2022 | 33 | $842.0K |
| Q2 2022 | 26 | $395.0K |
| Q1 2022 | 25 | $930.0K |
| Q4 2021 | 28 | $1.70M |
| Q3 2021 | 22 | $2.03M |
| Q2 2021 | 23 | $10.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Palisade Bio, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 105,367 | $173.9K | 0.00% | +53,367+102.6% | Added |
| Cetera Investment Advisers | 70,006 | $115.5K | 0.00% | +70,006 | New |
| Marex Group plc | 35,759 | $59.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,052 | $16.6K | 0.00% | +10,052 | New |
| UBS Group AG | 8,974 | $14.8K | 0.00% | +8,943+28,848.4% | Added |
| Tower Research Capital LLC (TRC) | 4,686 | $7.73K | 0.00% | +3,089+193.4% | Added |
| Federation des caisses Desjardins du Quebec | 100 | $165 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 21 | $35 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 10 | $16 | 0.00% | +1+11.1% | Added |
| Morgan Stanley | 7 | $12 | 0.00% | −133−95.0% | Reduced |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −8,200−100.0% | Sold out |